Clinical trial
A Phase 2, Observer-blind, Randomized, Controlled Study to Evaluate the Safety and Immunogenicity of Two Formulations of Investigational Meningococcal Groups ACYWX Conjugate Vaccine, Administered to Healthy Malian Children 12-16 Months of Age
NCT03295318 is registered in ClinicalTrials.gov with Serum Institute of India Pvt. Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Observer-blind, Randomized, Controlled Study to Evaluate the Safety and Immunogenicity of Two Formulations of Investigational Meningococcal Groups ACYWX Conjugate Vaccine, Administered to Healthy Malian Children 12-16 Months of Age
- Lead sponsor
- Serum Institute of India Pvt. Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 15, 2017
- Completion date
- August 31, 2018
- Enrollment
- 375 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.